MDGL

Madrigal Pharmaceuticals, Inc. Common Stock
Data: 2026-08-21
$516.74
Price
-0.45%
Change
$615.00
52W High
$392.97
52W Low

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Quick Stats
Aug 21, 2026

50.7

AI Score

HOLD

0.51

Volume Ratio

TBA

Next Earnings

17

+ve Days (30d)

13

-ve Days (30d)

MDGL Stock Summary

Last updated Aug 21, 2026

MDGL is currently trading at $516.74, positioned above its 200-day moving average of $514.01, indicating a long-term uptrend. The stock has a 52-week range of $392.965 to $615.

Technical Analysis: The 50-day moving average stands at $522.83, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 48.196, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.141, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates MDGL at 50.7/100 with a HOLD recommendation.

MDGL (Madrigal Pharmaceuticals, Inc. Common Stock) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 48.196
CMF (20) 0.141
ROC (10) 1.314
ADX (14) 13.392
Indicator Value
MACD (12,26,9) -0.668
AROONOSC (14) 50.0
WILLAMS %R (14) -50.217
MFI (14) 69.571
MDGL Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

MDGL Price vs Max Options Open Interest
MDGL Max Change In Options Open Interest

MDGL Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MDGL Daily Out of Money Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MDGL Daily In the Money Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MDGL Most Active Options by Volume(near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Madrigal Pharmaceuticals, Inc. Common Stock is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).

MDGL Moving Averages Analysis

Madrigal Pharmaceuticals, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 21, 2026

MDGL (Madrigal Pharmaceuticals, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 522.7
20 517.42
30 525.78
50 522.83
100 518.35
200 514.01

MDGL Fundamental Analysis

P/E (Forward) 666.6667
P/E (Trailing) --
Market Cap ($) 12.0 billion
Earnings/Share ($) -14
Net Profit Margin (%) -0.2532
Dividend/Share ($) --
EPS Estimate Current Year ($) -6.4925
EPS Estimate Next Year ($) 9.625
WallStreet Target Price ($) 678.06
Most Recent Quarter